Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines
出版年份 2021 全文链接
标题
Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines
作者
关键词
-
出版物
Frontiers in Immunology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-10-01
DOI
10.3389/fimmu.2021.708848
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19
- (2021) Robert L. Gottlieb et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
- (2021) Serge Bureau et al. Lancet Respiratory Medicine
- Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider
- (2021) Alessia Alunno et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study
- (2021) Hannah Bower et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical outcomes of COVID-19 in patients with rheumatic diseases: A systematic review and meta-analysis of global data
- (2021) Chuanhui Xu et al. AUTOIMMUNITY REVIEWS
- Extremely potent human monoclonal antibodies from COVID-19 convalescent patients
- (2021) Emanuele Andreano et al. CELL
- Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19
- (2021) Kathryn E. Stephenson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies – A Danish population-based cohort study
- (2021) Mohamed Attauabi et al. JOURNAL OF AUTOIMMUNITY
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- Sputnik V COVID-19 vaccine candidate appears safe and effective
- (2021) Ian Jones et al. LANCET
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial
- (2021) Raches Ella et al. LANCET INFECTIOUS DISEASES
- Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
- (2021) Xuping Xie et al. NATURE MEDICINE
- Baricitinib Therapy in Covid-19 Pneumonia — An Unmet Need Fulfilled
- (2021) Delia Goletti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
- (2021) Ivan O. Rosas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19
- (2021) Fasihul A Khan et al. THORAX
- An open label trial of anakinra to prevent respiratory failure in COVID-19
- (2021) Evdoxia Kyriazopoulou et al. eLife
- The Rheumatology Drugs for COVID-19 Management: Which and When?
- (2021) Fabiola Atzeni et al. Journal of Clinical Medicine
- SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases
- (2021) David Simon et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort
- (2021) Ulf M Geisen et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
- (2021) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- Response to: Correspondence on “SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response” by Bonelli et al
- (2021) Michael Bonelli et al. ANNALS OF THE RHEUMATIC DISEASES
- American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2
- (2021) Jeffrey R. Curtis et al. Arthritis & Rheumatology
- Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial
- (2021) Jean-Claude Tardif et al. Lancet Respiratory Medicine
- ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients
- (2021) Andrea Picchianti-Diamanti et al. Frontiers in Immunology
- Tolerance of COVID-19 vaccination in patients with systemic lupus erythematosus: the international VACOLUP study
- (2021) Renaud Felten et al. Lancet Rheumatology
- Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
- (2020) Peter Richardson et al. LANCET
- Convalescent plasma in Covid-19: Possible mechanisms of action
- (2020) Manuel Rojas et al. AUTOIMMUNITY REVIEWS
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
- (2020) Wen Zhang et al. CLINICAL IMMUNOLOGY
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
- (2020) Chuan Qin et al. CLINICAL INFECTIOUS DISEASES
- Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity
- (2020) Andrea Picchianti Diamanti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
- (2020) Fabrizio Cantini et al. JOURNAL OF INFECTION
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
- (2020) Jianjun Gao et al. BioScience Trends
- Low‐dose hydrocortisone in patients with COVID‐19 and severe hypoxia (COVID STEROID) trial—Protocol and statistical analysis plan
- (2020) Marie Warrer Petersen et al. ACTA ANAESTHESIOLOGICA SCANDINAVICA
- EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2
- (2020) Robert BM Landewé et al. ANNALS OF THE RHEUMATIC DISEASES
- Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
- (2020) Hui Wang et al. CELL
- Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells
- (2020) Yunlong Cao et al. CELL
- COVID‐19 vaccine‐readiness for anti‐CD20‐depleting therapy in autoimmune diseases
- (2020) D. Baker et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation
- (2020) Emilie Seydoux et al. IMMUNITY
- Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study
- (2020) Fabrizio Cantini et al. JOURNAL OF INFECTION
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
- (2020) Mark J. Mulligan et al. NATURE
- SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
- (2020) Nina Le Bert et al. NATURE
- Convergent antibody responses to SARS-CoV-2 in convalescent individuals
- (2020) Davide F. Robbiani et al. NATURE
- Next-generation vaccine platforms for COVID-19
- (2020) Debby van Riel et al. NATURE MATERIALS
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19
- (2020) Raphaël Cauchois et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum
- (2020) C. Louapre et al. REVUE NEUROLOGIQUE
- Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain
- (2020) Paloma Montero-Escribano et al. Multiple Sclerosis and Related Disorders
- Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019
- (2020) Spyridon G. Deftereos et al. JAMA Network Open
- Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
- (2020) Takuya Sekine et al. CELL
- Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19
- (2020) Naoki Kaneko et al. CELL
- Comparative Survival Analysis of Immunomodulatory Therapy for COVID-19 'Cytokine Storm'
- (2020) Sonali Narain et al. CHEST
- Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review
- (2020) Fabrizio Cantini et al. DRUGS
- Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19
- (2020) Pierre-François Dequin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19
- (2020) Bruno M. Tomazini et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
- (2020) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
- (2020) Shengli Xia et al. LANCET INFECTIOUS DISEASES
- Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study
- (2020) Sean T. H. Liu et al. NATURE MEDICINE
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial
- (2020) Jesús Villar et al. Trials
- Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac – PROFISCOV: A structured summary of a study protocol for a randomised controlled trial
- (2020) Ricardo Palacios et al. Trials
- Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
- (2020) Olivier Hermine et al. JAMA Internal Medicine
- Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia
- (2020) Carlo Salvarani et al. JAMA Internal Medicine
- Colchicine to Weather the Cytokine Storm in Hospitalized Patients with COVID-19
- (2020) Luigi Brunetti et al. Journal of Clinical Medicine
- Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses
- (2020) Rinke Bos et al. npj Vaccines
- Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production
- (2020) Yuezhou Chen et al. CELL
- Rational development of a human antibody cocktail that deploys multiple functions to confer Pan-SARS-CoVs protection
- (2020) Hangping Yao et al. CELL RESEARCH
- Structure-based development of human antibody cocktails against SARS-CoV-2
- (2020) Nan Wang et al. CELL RESEARCH
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
- (2020) Maheshi N Ramasamy et al. LANCET
- The COVID-19 pandemic: consequences for nephrology
- (2020) Annette Bruchfeld Nature Reviews Nephrology
- Rheumatic disease and COVID-19: epidemiology and outcomes
- (2020) Kimme L. Hyrich et al. Nature Reviews Rheumatology
- A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
- (2020) Peter Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease
- (2020) Ruth Fernandez-Ruiz et al. Translational Research
- Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: Results of a prospective, open-label, interventional study
- (2020) A. Balkhair et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
- (2020) Yanjun Zhang et al. LANCET INFECTIOUS DISEASES
- Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases
- (2019) Anniina T. Virtanen et al. BIODRUGS
- 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
- (2019) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
- (2019) Yushun Wan et al. JOURNAL OF VIROLOGY
- Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial
- (2018) Jin Kyun Park et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical characteristics and risk factors of infections in patients with systemic lupus erythematosus
- (2018) Chengcheng Hou et al. CLINICAL RHEUMATOLOGY
- Self-Amplifying Replicon RNA Delivery to Dendritic Cells by Cationic Lipids
- (2018) Pavlos C. Englezou et al. Molecular Therapy-Nucleic Acids
- Update on colchicine, 2017
- (2017) Anastasia Slobodnick et al. RHEUMATOLOGY
- Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine
- (2017) Meliha C. Kapetanovic et al. VACCINE
- Review: Cytokine Storm Syndrome: Looking Toward the Precision Medicine Era
- (2017) Edward M. Behrens et al. Arthritis & Rheumatology
- Therapeutic management of patients with rheumatoid arthritis and associated interstitial lung disease: case report and literature review
- (2016) Andrea Picchianti Diamanti et al. Therapeutic Advances in Respiratory Disease
- The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis
- (2015) Kevin L Winthrop et al. ANNALS OF THE RHEUMATIC DISEASES
- Opsonic and Antibody Responses to Pneumococcal Polysaccharide in Rheumatoid Arthritis Patients Receiving Golimumab Plus Methotrexate
- (2015) Kiyoshi Migita et al. MEDICINE
- Colchicine—Update on mechanisms of action and therapeutic uses
- (2015) Ying Ying Leung et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients
- (2015) Kiyoshi Migita et al. ARTHRITIS RESEARCH & THERAPY
- Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus
- (2015) Kiyoshi Migita et al. ARTHRITIS RESEARCH & THERAPY
- Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA)
- (2014) Clifton O Bingham et al. ANNALS OF THE RHEUMATIC DISEASES
- Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins
- (2014) Sheng-Fan Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009-10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals
- (2014) F. Milanetti et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Investigation of clinical characteristics as predictive factors for the humoral immune response to the influenza vaccine in patients with rheumatoid arthritis
- (2014) Toshiaki Kogure et al. CLINICAL RHEUMATOLOGY
- Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists
- (2014) Valentina Germano et al. Journal of Translational Medicine
- Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis
- (2014) Meliha C Kapetanovic et al. ARTHRITIS RESEARCH & THERAPY
- Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy
- (2013) Shunsuke Mori et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens
- (2013) Richard D Antrobus et al. MOLECULAR THERAPY
- High Disease Activity: An Independent Factor for Reduced Immunogenicity of the Pandemic Influenza A Vaccine in Patients With Juvenile Systemic Lupus Erythematosus
- (2013) Lucia M. A. Campos et al. ARTHRITIS CARE & RESEARCH
- Effect of Methotrexate, Anti-Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- (2013) Charlotte Hua et al. ARTHRITIS CARE & RESEARCH
- Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis
- (2013) Meliha Crnkic Kapetanovic et al. ARTHRITIS RESEARCH & THERAPY
- Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry
- (2012) Fabiola Atzeni et al. AUTOIMMUNITY REVIEWS
- Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease
- (2012) Apostolos Kontzias et al. CURRENT OPINION IN PHARMACOLOGY
- Into the Eye of the Cytokine Storm
- (2012) J. R. Tisoncik et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy?
- (2012) E. F. Borba et al. RHEUMATOLOGY
- New insights into chronic inflammation-induced immunosuppression
- (2012) Julia Kanterman et al. SEMINARS IN CANCER BIOLOGY
- Abatacept and reduced immune response to pandemic 2009 influenza A/H1N1 vaccination in patients with rheumatoid arthritis
- (2012) Ana C. Ribeiro et al. ARTHRITIS CARE & RESEARCH
- Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases
- (2011) C. G. S. Saad et al. ANNALS OF THE RHEUMATIC DISEASES
- Pneumococcal antibody levels after pneumovax in patients with rheumatoid arthritis on methotrexate
- (2011) E. Coulson et al. ANNALS OF THE RHEUMATIC DISEASES
- Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice
- (2011) A. C. M. Ribeiro et al. ANNALS OF THE RHEUMATIC DISEASES
- Influenza vaccination responses in human systemic lupus erythematosus: Impact of clinical and demographic features
- (2011) Sherry R. Crowe et al. ARTHRITIS AND RHEUMATISM
- Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study
- (2011) S. Adler et al. RHEUMATOLOGY
- The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab
- (2011) U. Arad et al. VACCINE
- Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases
- (2011) Ori Elkayam et al. ARTHRITIS CARE & RESEARCH
- Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor
- (2011) James J Kobie et al. ARTHRITIS RESEARCH & THERAPY
- The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses
- (2011) William G Dixon et al. ARTHRITIS RESEARCH & THERAPY
- Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFα blockers: Safety and immunogenicity
- (2009) S. Salemi et al. CLINICAL IMMUNOLOGY
- Vaccines: Vaccination in Patients with Chronic Rheumatic or Autoimmune Diseases
- (2008) T. Glück et al. CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More